case_images: PMC9909044_01
case_images: The appearance of an erythematous maculopapular rash in the patient's limbs: (a) bilateral lower limbs and (b) right thigh.
case_images: 10.1177_2050313X231154317-fig1.jpg
case_images: PMC9909044_01_10.1177_2050313X231154317-fig1.jpg
case_images: fig1-2050313X231154317
case_images: The skin eruption recurred 3 days later, and a punch skin biopsy showed minimal superficial dermal perivascular lymphocytic cell infiltrate consistent with perivascular interface dermatitis, a possible morbilliform drug eruption (Figure 1).
case_images: Computer tomography scan of the neck showing bilateral sub-centimeter cervical lymph nodes, some of them showed central necrosis.
case_images: 10.1177_2050313X231154317-fig2.jpg
case_images: PMC9909044_01_10.1177_2050313X231154317-fig2.jpg
case_images: fig2-2050313X231154317
case_images: Computer tomography of the neck revealed bilateral sub-centimeter cervical lymph nodes; some lymph nodes showed central necrosis (Figure 2).
case_images: Lymph node histopathology showing histiocytes, lymphocytes, scattered eosinophils, karyorrhexis, and apoptotic bodies in a necrotic background with diffuse and strong positive CD68.
case_images: 10.1177_2050313X231154317-fig3.jpg
case_images: PMC9909044_01_10.1177_2050313X231154317-fig3.jpg
case_images: fig3-2050313X231154317
case_images: Moreover, lymph node histopathology showed partially effaced lymph nodes composed of histiocytes, lymphocytes, scattered eosinophils, karyorrhexis, and apoptotic bodies in a necrotic background with immunohistochemistry diffuse and strongly positive for CD68 (Figure 3).
case_images: Bone marrow biopsy showing hemophagocyte in the center of the slide with different view (a-c) blue arrows. Histiocytes seen in the mid of the slide (d) green arrow.
case_images: 10.1177_2050313X231154317-fig4.jpg
case_images: PMC9909044_01_10.1177_2050313X231154317-fig4.jpg
case_images: fig4-2050313X231154317
case_images: Limited flow cytometry showed 14% lymphocytes with 70% T cells (positive CD2, CD3, CD5, CD7, CD8), 25% B cells (CD19), and NK-cell of 5% (CD5-/CD19-) (Figure 4).